1. Ecogenetics, pharmacogenetics, and complex genetic disease: from Toll to Toll-House

   • F. C. Luft

   Original Article 17 November 1999 Pages: 751 - 753

2. Prediction of nonsynonymous single nucleotide polymorphisms in human disease-associated genes

   • Shamil Sunyaev
   • Jens Hanke
   • Peer Bork

   Bioinformatics 08 February 2014 Pages: 754 - 760

3. DNA chip technology ante portas

   • Klaus Kasimir Wilgenbus
   • Peter Lichter

   Review 18 November 1999 Pages: 761 - 768

4. Mechanisms of brain-mediated systemic anti-inflammatory syndrome causing immunodepression

   • Christian Woiciechowsky
   • Britta Schöning
   • Wolf-Dietrich Döcke

   Review 27 October 1999 Pages: 769 - 780

5. Angiotensin-converting enzyme gene I/D polymorphism and renal disease

   • Gerjan Navis
   • Frank G.H. van der Kleij
   • Paul E. de Jong

   Review 09 November 1999 Pages: 781 - 791

6. Farnesylthiosalicylic acid inhibits the growth of human Merkel cell carcinoma in SCID mice

   • Burkhard Jansen
   • Elisabeth Heere-Ress
   • Klaus Wolff

   Original Article 06 November 1999 Pages: 792 - 797

7. Ornithine decarboxylase gene expression in Castleman's disease

   • Lucia Malaguarnera
   • Maria Rosaria Pilastro
   • Angelo Messina

   Original Article 16 November 1999 Pages: 798 - 803

8. Expression of ACE mRNA in the human atrial myocardium is not dependent on left ventricular function, ACE inhibitor therapy, or the ACE I/D genotype

   • E. Spruth
   • H.R. Zurbrügg
   • V. Regitz-Zagrosek

   Original Article 04 November 1999 Pages: 804 - 810

9. Paul-Martini-Award 2000

   Announcement 08 February 2014 Pages: 811 - 811